Cahill Led Transaction Named a Cross Border Deal of the Year by The M&A Advisor
The transaction between a leading provider of research models and services, and a leading global life sciences company that is integrated in guiding patient care, has been named a Cross Border Deal of the Year ($100MM–$1B) by The M&A Advisor in its 18th Annual M&A Advisor Awards. Cahill represented the Company in connection with a complex, nearly-simultaneous, four-part M&A agreement, in which the Company undertook a sale, a spin-out, a purchase by the spin-out, and a continuing services agreement between the Company and a global life sciences company. The Cahill team representing the Company was led by corporate partners Kimberly C. Petillo-Décossard, Jonathan A. Schaffzin, and Ross E. Sturman; antitrust partner Elai Katz and counsel Lauren Rackow; executive compensation and benefits counsel Mark J. Gelman; and tax partner Craig M. Horowitz and associate Samir Kurani.
Roger Aguinaldo, founder of The M&A Advisor, commented “The award recipients represent the finest in the M&A industry in 2019 and earned these honors by standing out in a group of extremely impressive finalists.” This year, over 200 nominees, representing over 500 companies, became finalists for the awards. An independent judging committee of 28 top M&A industry experts determined the ultimate recipients of the awards which were revealed “Academy-Award style” at the 18th Annual M&A Advisor Awards Gala on November 19, 2019.